admin

This is an amazing week to consider biotech stocks. Big news by the U.S. Food & Drug Administration (which we’ll get to momentarily) shows the benefits and outsized gains you can enjoy by choosing the right biotech stock. Biotech companies have the potential to be big winners because of their very nature. They’re at the

Robotics and automation are a necessity for the future. Be it for operational efficiency or cost controls, companies are going to adopt automation. It’s estimated that the industrial robotics market will be worth $60.56 billion by 2030. The healthcare robotics market specifically is expected to be worth $58.2 billion by 2030. The growth of robotics

Blue-chip stocks are always profitable or on the verge of entering the black, and the Street is currently in love with profitable companies. In my own portfolio, nearly all of the stocks of profitable companies have climbed significantly in 2023, and the reverse is true for the unprofitable firms whose shares I own. I believe

Alphabet (NASDAQ:GOOGL,NASDAQ:GOOG) stock has tumbled sharply, due to the market overreacting to negative news. The latest occurrence of the phenomenon, which I’ll refer to as GOOG’s “fair-weather pattern,” occurred following the company’s latest earnings release. So, what is the relevance of this “pattern” to existing and/or news investors in GOOG stock? While it may be

Many people know Amazon (NASDAQ:AMZN) as a place to buy products online in practically every category. Yet, the company is also a cloud king with its Amazon Web Services business. Plus, Amazon deploys artificial intelligence in some of its services. So, while AMZN stock isn’t necessarily ultra-cheap, it gets a “B” grade and could move higher in 2024.

In a rapidly evolving business landscape, innovation and adaptability are the cornerstones of success. The quest for stellar turnaround stocks is a pursuit that captures investors’ imaginations. The article delves into the turnaround strategies of three companies whose stocks have faced their fair share of challenges, but are now poised for remarkable comebacks. Discover how

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader pressures, generally manages to march to its own beat, the underlying innovation may offer an alternative upside pathway. By now, you’ve likely heard about the impressive third-quarter U.S. GDP print,

While the rest of Wall Street may be basking in the glow of screaming-hot economy, contrarian investors may want to consider the best stocks for a volatile market. Just like in a game of baseball, all it takes is one bad inning to see a big lead evaporate. Yes, U.S. GDP for the third quarter

Dividend investing is a robust and stable investment strategy that has helped many investors increase their portfolios over time. Investors are attracted to dividend stocks that are undervalued. This is because they give individuals guaranteed income within an expected time frame. Typically, most investment strategies are ones in which the rate of return for the

We’re still in the initial stages of a massively disruptive artificial intelligence (AI) boom. Big Tech is investing billions of dollars into it. Grand View Research saying we could be looking at a $1.8 trillion opportunity by 2030. And so far, it’s changing just about everything about everything. That includes healthcare–which could create a $188 billion

The “meme mania” that once propelled AMC Entertainment (NYSE:AMC) stock to lofty price levels has long left the scene. Even as a speculative trade, AMC is no longer one of the strong opportunities among entertainment stocks. The better plays include other movie theater stocks. One of AMC’s key publicly traded peers sports a valuation more

The holidays are fast approaching, meaning it’s time to start making a gift list and checking it twice. Figuring out what to get the grandkids can be particularly difficult for people. Beyond any generational divide that might exist, it can be hard to figure out what the grandkids already have and what they might need.

As the airline sector emerges from the Covid-led turbulence, investors want to cash in on the resilient airline stocks to buy. While grounded fleets once painted a grim picture, the industry’s recent spike in travel demand is a major tailwind for top-line expansion ahead. Nevertheless, despite this resurgence, the sector isn’t without its share of

Without contest, Nvidia (NASDAQ:NVDA) is the best artificial intelligence (AI) stock on the current market. No matter how you slice it, Nvidia has the best chips for AI and machine learning at this point. And undeniably, the company has done the work to get to where it is today and deserves the accolades.  But tremendous

There has been plenty of noise surrounding electric vehicle (EV) stocks lately. Sentiment ricochets between proclamations of booming growth one day to proliferating fears about slowing EV sales the very next quarter. There’s also plenty of debate around the competitive set within this sector, particularly between EV juggernaut Tesla (NASDAQ:TSLA) and upstart Rivian (NASDAQ:RIVN). Let’s

Sound financial performance indicates that a company may be a good investment choice. The earnings season provides investors another window of opportunity to see which reporting companies exceeded expectations with solid financials and positive outlooks. These earnings winners present new and experienced investors with opportunities to get in on a company with strong growth potential. 

Warren Buffett loves dividends. And this year Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) will collect $5.7 billion in dividend checks, half of which will come from just three companies. But only a handful of those stocks have a long enough track record of raising their payout for 25 years or more. That’s a feat that would qualify them

The fields of gene editing and gene therapy have been growing since the first draft of the human genome map was finished in 2003. In 2022, gaps in that map were completed. But even before then, the roadmap gave researchers the opportunity to develop gene therapies to correct genetic abnormalities. Gene editing, which seeks to